Dose-Volume Factors Predicting Airway Stenosis After SBRT for Ultra-Central Lung Tumors

被引：1
|
作者：
Jackson, A. [1 ]
Wang, C. [2 ]
Yorke, E. [1 ]
Geldblum, D. [2 ]
Apte, A. [1 ]
Yang, J. [1 ]
Rimner, A. [2 ]
Wu, A. [2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Med Phys, 1275 York Ave, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Radiat Oncol, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Ultra-central SBRT Stenosis;
D O I：
10.1016/j.jtho.2019.08.506
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA02.06
引用
收藏
页码：S253 / S254
页数：2
相关论文
共 50 条
  • [1] Dose-volume factors predicting esophageal after SBRT for ultra-central lung tumors
    Jackson, A.
    Wang, C.
    Yorke, E.
    Gelblum, D.
    Apte, A.
    Yang, J.
    Rimner, A.
    Wu, A.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S836 - S836
  • [2] Dose-volume Factors Predicting Radiation Pneumonitis after SBRT for Ultra-central Lung Tumors
    Jackson, A.
    Wang, C.
    Yorke, E. D.
    Gelblum, D.
    Apte, A.
    Yang, J.
    Rimner, A.
    Wu, A. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E510 - E511
  • [3] Improving geometric sparing and therapeutic effectiveness of lung SBRT for central and ultra-central tumors
    Fakir, Hatim
    Randhawa, Gurpreet K.
    Millman, Barbara
    Laba, Joanna
    MEDICAL DOSIMETRY, 2021, 46 (04) : 398 - 403
  • [4] Toxicity and Local Control in "Ultra-Central" Lung Tumors Treated With SBRT or High-Dose Hypofractionated RT
    Wang, C.
    Sidiqi, B.
    Yorke, E.
    Mcknight, D.
    Dick-Godfrey, R.
    Torres, D.
    Gelblum, D.
    Rimner, A.
    Wu, A.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S357 - S357
  • [5] Toxicity and Local Control in "Ultra-Central" Lung Tumors Treated with Stereotactic Body Radiation Therapy (SBRT)
    Wang, C.
    Sidiqi, B. U.
    Yorke, E. D.
    McKnight, D.
    Dick-Godfrey, R.
    Torres, D.
    Gelblum, D.
    Rimner, A.
    Wu, A. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S10 - S10
  • [6] Safety and Efficacy of Moderate-intensity SBRT for Ultra-central Lung tumor
    Park, S.
    Rim, C. H.
    Yoon, W. S.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1056 - S1057
  • [7] Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors
    Chaudhuri, Aadel A.
    Tang, Chad
    Binkley, Michael S.
    Jin, Michelle
    Wynne, Jacob F.
    von Eyben, Rie
    Hara, Wendy Y.
    Trakul, Nicholas
    Loo, Billy W., Jr.
    Diehn, Maximilian
    LUNG CANCER, 2015, 89 (01) : 50 - 56
  • [8] Predictors of Pulmonary and Other Thoracic Complications after Lung Stereotactic Body Radiotherapy (SBRT) for Primary or Metastatic Lung Tumors: Dose-volume Analysis
    Mangona, V.
    Grills, I. S.
    Yan, D.
    McInemey, E.
    Martin, S.
    Kestin, L. L.
    McGrath, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S161 - S161
  • [9] Chest wall pain in lung SBRT patients: dose-volume correlations
    Munoz-Montplet, C.
    Fuentes-Raspall, R.
    Jurado-Bruggeman, D.
    Gomez-Horsfield, B.
    Font-Planas, O.
    Lambisto-Castro, D.
    Agramunt-Chaler, S.
    Onses-Segarra, A.
    Romera-Martinez, I.
    Massana-Melchor, E.
    Eraso-Urien, A.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1822 - S1825
  • [10] Safety of judicious stereotactic ablative radiotherapy for central and ultra-central lung tumors
    Galaverni, Marco
    Colombo, Federico
    Dell'Anna, Cristina
    Lattanzi, Elisabetta
    Grondelli, Claudia
    Salaroli, Francesco
    Renna, Ilaria
    Gianni, Stella
    Ceccon, Giovanni
    Bergamini, Maria Luisa
    D'Abbiero, Nunziata
    Simoni, Nicola
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1706 - S1708
12345